Literature DB >> 3299029

Shiga and Shiga-like toxins.

A D O'Brien, R K Holmes.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3299029      PMCID： PMC373104          DOI： 10.1128/mr.51.2.206-220.1987

Source DB:  PubMed          Journal:  Microbiol Rev        ISSN： 0146-0749


× No keyword cloud information.
  101 in total

1.  Comparative studies of five heat-labile toxic products of Escherichia coli.

Authors:  J Konowalchuk; N Dickie; S Stavric; J I Speirs
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

2.  Inhibition of protein synthesis in intact HeLa cells by Shigella dysenteriae 1 toxin.

Authors:  J E Brown; S W Rothman; B P Doctor
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

3.  Inhibition of protein synthesis by Shiga toxin: activation of the toxin and inhibition of peptide elongation.

Authors:  J E Brown; M A Ussery; S H Leppla; S W Rothman
Journal:  FEBS Lett       Date:  1980-08-11       Impact factor: 4.124

4.  Immunization with Shigella dysenteriae type 1: evaluation of antitoxic immunity in prevention of experimental disease in rhesus monkeys (Macaca mulatta).

Authors:  J McIver; G F Grady; S B Formal
Journal:  J Infect Dis       Date:  1977-09       Impact factor: 5.226

5.  Haemolytic-uraemic syndrome complicating shigella dystentery in south Indian children.

Authors:  P Raghupathy; A Date; J C Shastry; A Sudarsanam; M Jadhav
Journal:  Br Med J       Date:  1978-06-10

6.  Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes.

Authors:  F Koster; J Levin; L Walker; K S Tung; R H Gilman; M M Rahaman; M A Majid; S Islam; R C Williams
Journal:  N Engl J Med       Date:  1978-04-27       Impact factor: 91.245

7.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

8.  Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.

Authors:  A D O'Brien; G D LaVeck; D E Griffin; M R Thompson
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

9.  Isolation and characterization of Shigella shigae cytotoxin.

Authors:  S Olsnes; K Eiklid
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

10.  Pathogenesis of Shigella diarrhea. VII. Evidence for a cell membrane toxin receptor involving beta1 leads to 4-linked N-acetyl-D-glucosamine oligomers.

Authors:  G T Keusch; M Jacewicz
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307
View more
  225 in total

1.  Effect of Shiga toxin 2 on water and ion transport in human colon in vitro.

Authors:  P Fiorito; J M Burgos; M F Miyakawa; M Rivas; G Chillemi; D Berkowski; E Zotta; C Silberstein; C Ibarra
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

Review 2.  Bacterial toxins in pediatric infectious diseases.

Authors:  D R Balkundi; A Kumar
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

3.  Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7.

Authors:  G L Kolling; K R Matthews
Journal:  Appl Environ Microbiol       Date:  1999-05       Impact factor: 4.792

4.  Escherichia Coli O157 H7 and Shiga-like-toxin- producing Escherichia Coli in China.

Authors:  Jian-Guo Xu; Bo-Kun Cheng; Huai-Qi Jing
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

5.  Restriction-site-specific PCR as a rapid test to detect enterohemorrhagic Escherichia coli O157:H7 strains in environmental samples.

Authors:  R Kimura; R E Mandrell; J C Galland; D Hyatt; L W Riley
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

6.  Shiga toxin 1 from Escherichia coli blocks activation and proliferation of bovine lymphocyte subpopulations in vitro.

Authors:  C Menge; L H Wieler; T Schlapp; G Baljer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

7.  Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.

Authors:  Jun Fujii; Mariko Naito; Takashi Yutsudo; Sohkichi Matsumoto; Daniel P Heatherly; Takeshi Yamada; Hideyuki Kobayashi; Shin-Ichi Yoshida; Tom Obrig
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

8.  Top-down proteomic identification of Shiga toxin 2 subtypes from Shiga toxin-producing Escherichia coli by matrix-assisted laser desorption ionization-tandem time of flight mass spectrometry.

Authors:  Clifton K Fagerquist; William J Zaragoza; Omar Sultan; Nathan Woo; Beatriz Quiñones; Michael B Cooley; Robert E Mandrell
Journal:  Appl Environ Microbiol       Date:  2014-02-28       Impact factor: 4.792

9.  Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release.

Authors:  Pamela Cameron; Susan J Smith; Mark A Giembycz; Dino Rotondo; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

10.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.